Search results for "FDA update"
All Ameridose unexpired products recalled
All unexpired products distributed by Ameridose, LLC, are being recalled, the FDA announced last week.
https://immattersacp.org/weekly/archives/2012/11/06/7.htm
6 Nov 2012
Troponin and other diagnostic tests recalled
A number of cardiovascular diagnostic tests are being recalled for possible inaccuracy of their results, the FDA announced last week.
https://immattersacp.org/weekly/archives/2012/07/17/7.htm
17 Jul 2012
Contraceptive pills recalled
Twenty-eight lots of oral contraceptives have been recalled by manufacturer Pfizer because some blister packs may contain an inexact count of inert or active-ingredient tablets and the tablets may be out of sequence.
https://immattersacp.org/weekly/archives/2012/02/07/6.htm
7 Feb 2012
Possibility of mixed drugs from Endo Pharmaceuticals
The FDA recently warned physicians and the public about the possibility of packaging mix-ups of some prescription opiate medications and over-the-counter non-opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health.
https://immattersacp.org/weekly/archives/2012/01/24/8.htm
24 Jan 2012
Expanded approval on rivaroxaban, reassurance on dabigatran
This regulatory update covers an expanded indication for rivaroxaban and an announcement that bleeding rates do not appear to be higher with dabigatran than with warfarin.
https://immattersacp.org/archives/2013/01/fda.htm
1 Jan 2013
Generic irbesartan, escitalopram, ibandronate approved
This regulatory update includes a revision to the label of drospirenone-containing contraceptives and approval of the first generic versions of Avapro (irbesartan) and Avalide (irbesartan and hydrochlorothiazide) tablets for the treatment of high blood pressure.
https://immattersacp.org/archives/2012/06/fda.htm
1 Jun 2012
Proton-pump inhibitors to carry warning about C. diff
The FDA warned last week that proton-pump inhibitors (PPIs) may be associated with an increased risk of Clostridium difficile–associated diarrhea (CDAD).
https://immattersacp.org/weekly/archives/2012/02/14/7.htm
14 Feb 2012
Boxed warning for clopidogrel: reduced effects for certain patients
A boxed warning was added to the label for clopidogrel (Plavix) to warn of reduced effectiveness in patients who metabolize the drug poorly, the FDA said last week.
https://immattersacp.org/weekly/archives/2010/03/23/9.htm
23 Mar 2010
Concentration and dosing of Tamiflu changed
The concentration of oseltamivir phosphate (Tamiflu) oral suspension has been reduced, and labels and dosing have changed accordingly, the FDA announced last week.
https://immattersacp.org/weekly/archives/2011/07/19/8.htm
19 Jul 2011
Heparin, saline solutions recalled for possible contamination
Warnings, recalls, label changes, and approvals.
https://immattersacp.org/archives/2008/03/eighteen.htm
1 Mar 2008